CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,240,600 | -41.9% | 130,000 | -37.3% | 1.01% | -53.6% |
| Q1 2023 | $7,301,925 | -36.3% | 207,500 | -17.0% | 2.19% | -45.1% |
| Q4 2022 | $11,455,000 | -10.1% | 250,000 | -4.9% | 3.98% | -24.3% |
| Q3 2022 | $12,742,000 | +7.2% | 263,000 | -13.1% | 5.26% | -1.8% |
| Q2 2022 | $11,885,000 | -20.6% | 302,500 | -25.6% | 5.36% | +15.3% |
| Q1 2022 | $14,963,000 | -43.4% | 406,500 | -29.9% | 4.65% | -17.1% |
| Q4 2021 | $26,436,000 | +27.5% | 580,000 | 0.0% | 5.61% | +44.8% |
| Q3 2021 | $20,729,000 | +80.6% | 580,000 | 0.0% | 3.87% | +103.1% |
| Q2 2021 | $11,478,000 | -14.9% | 580,000 | 0.0% | 1.91% | -3.8% |
| Q1 2021 | $13,491,000 | +11.4% | 580,000 | -0.5% | 1.98% | +25.3% |
| Q4 2020 | $12,111,000 | +167.9% | 582,800 | +179.1% | 1.58% | +79.0% |
| Q3 2020 | $4,521,000 | -36.7% | 208,800 | -31.1% | 0.88% | -38.7% |
| Q2 2020 | $7,143,000 | – | 303,050 | – | 1.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |